Effects of cholinergic system of dorsal hippocampus of rats on MK-801 induced anxiolytic-like behavior

Neuroscience Letters

Volumn 505, Issue 2, 2011, Pages 65-70

  Zarrindast, Mohammad Reza ^{a,b,c,d,e,f,g}   Nasehi, Mohammad ^h   Piri, Morteza ⁱ   Heidari, Negar ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^f INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^g Iranian Neuroscience Research Network   (Iran)

^h ISLAMIC AZAD UNIVERSITY   (Iran)

ⁱ ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anxiolytic like response; Dorsal hippocampus; Elevated plus maze; Mecamylamine; MK 801; Rat(s); Scopolamine

Indexed keywords

DIZOCILPINE; MECAMYLAMINE; SCOPOLAMINE;

ANXIETY; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; GROOMING; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE;

ACETYLCHOLINE; ANIMALS; ANXIETY DISORDERS; CA1 REGION, HIPPOCAMPAL; CHOLINERGIC FIBERS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; MALE; RATS; RATS, WISTAR;

EID: 81055156655     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.08.009     Document Type: Article

References (17)

1. Azami N.S., Piri M., Oryan S., Jahanshahi M., Babapour V., Zarrindast M.R. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol. Learn. Mem. 2010, 93:455-462.
2. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N.P., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur. J. Pharmacol. 2009.
3. Brioni J.D., O'Neill A.B., Kim D.J., Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 1993, 238:1-8.
4. Degroot A., Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res. 2002, 949:60-70.
5. Engin E., Treit D., Dickson C.T. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 2009, 161:359-369.
6. File S.E., Gonzalez L.E., Andrews N. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors. Behav. Neurosci. 1998, 112:352-359.
7. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 2000, 66:65-72.
8. Hargreaves E.L., Cain D.P. Hyperactivity, hyper-reactivity, and sensorimotor deficits induced by low doses of the N-methyl-d-aspartate non-competitive channel blocker MK801. Behav. Brain Res. 1992, 47:23-33.
9. Hughes J.W., Tomlinson A., Blumenthal J.A., Davidson J., Sketch M.H., Watkins L.L. Social support and religiosity as coping strategies for anxiety in hospitalized cardiac patients. Ann. Behav. Med. 2004, 28:179-185.
10. Kent J.M., Mathew S.J., Gorman J.M. Molecular targets in the treatment of anxiety. Biol. Psychiatry 2002, 52:1008-1030.
11. Markram H., Segal M. Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine. J. Physiol. 1990, 427:381.
12. Moreira K.M., Ferreira T.L., Fornari R.V., Figueredo L.Z.P., Oliveira M.G.M. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task. Brain Res. Bull. 2005, 67:504-508.
13. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press, London UK. 6rd ed.
14. Rakovska A., Kiss J.P., Raichev P., Lazarova M., Kalfin R., Djambazova E. The non-competitive AMPA receptor antagonist (GYKI 52466) blocks quisqualate-induced acetylcholine release from the rat hippocampus and striatum: an in vivo microdialysis study. Neurochem. Int. 2002, 40:419-426.
15. Tikhonov D.B., Magazanik L.G. Origin and molecular evolution of ionotropic glutamate receptors. Neurosci. Behav. Physiol. 2009, 39:763-773.
16. Zarrindast M.R., Homayoun H., Babaie A., Etminani A., Gharib B. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur. J. Pharmacol. 2000, 407:145-158.
17. Zarrindast M.R., Solati J., Oryan S., Parivar K. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology 2008, 82:276-284.